Sociodemographic and Clinical Factors Associated With Nirsevimab Receipt Among Children Aged Younger Than 20 Months in the New Vaccine Surveillance Network in 2023 to 2025

Hospital Pediatrics · Published 2026-08-27 · Journal article · DOI 10.1542/hpeds.2025-009168

Free full text

Authors (20)

Zheyi Teoh, Ayzsa Tannis, Erin Sullivan, Julie A. Boom, Natasha Halasa, Marian G. Michaels, Daniel C. Payne, Leila C. Sahni, Jennifer Schuster, Rangaraj Selvarangan, Mary Allen Staat, Laura S. Stewart, Peter G. Szilagyi, Geoffrey A. Weinberg, John V. Williams, Fatimah S. Dawood, Eileen J. Klein, Heidi Moline, Janet A. Englund, Danielle M. Zerr

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Teoh, Z., Tannis, A., Sullivan, E., et al. (2026). Sociodemographic and Clinical Factors Associated With Nirsevimab Receipt Among Children Aged Younger Than 20 Months in the New Vaccine Surveillance Network in 2023 to 2025. Hospital Pediatrics. https://doi.org/10.1542/hpeds.2025-009168

Related articles